Latest News

Sports, leisure and hospitality SaaS technology provider MSL Solutions Limited (ASX: MSL, “MSL” or “the Company) is excited to announce the appointment of Dr Sarah Kelly to the MSL Board as Non-Executive Director.

Dr Kelly has over 20 years of combined experience within the sports, marketing, law, education and waste management sectors, having served on a range of corporate, government and not-for-profit boards. Passionate about sports and its impacts on local, national and international communities, Sarah is an Associate Professor in Law and Marketing at the University of Queensland and an experienced commercial lawyer. She is globally known for her research, teaching and consulting in the sports field and is also leading a research hub at UQ in Trust, Ethics and Governance.

Sarah currently serves as a non-executive director on several boards, including as Deputy Chair of the Brisbane Lions AFL Football Club, Deputy Chair of Tourism and Events Qld, ASX-listed company Australian Family Lawyers and the Wandering Warriors.

She provides strategic mentorship to sports technology start-up companies and current projects are focussed upon esports, women’s sport, sponsorship strategy, sports integrity and mega event legacy. She is the Queensland Chapter Leader for the Minerva Network, a national social enterprise concerned with providing mentoring to professional sportswomen. In 2021, she was awarded an Order of Australia Medal for her services to sports administration and to tertiary education.

MSL Executive Chairman, Tony Toohey said:

“As MSL continues its growth and expansion phase, it’s appropriate to broaden and enhance the skills and expertise at Board level. We are extremely pleased to invite Dr Sarah Kelly, a highly experienced corporate leader and acknowledged academic, to join MSL as a Non-Executive Director.

Dr Kelly is already heavily involved in the sports tourism and event industries throughout Australia these skills align with MSL key target sectors”.

MSL’s 1st Half FY22 results, combined with a full schedule of contracted but not yet recognised revenues in 2H FY22, the full benefit of the OrderMate acquisition and balance sheet strength, creates a positive outlook for the full financial year and into FY23.

The Appendix 3X for Dr Kelly is attached to this announcement.